Melinta Therap Drug Patent Portfolio
Melinta Therap's Family Patents
Clinical Trials
Recent Clinical Trials by Melinta Therap:
| Title | Lead Sponsor | Collaborators | Status | Phases |
|---|---|---|---|---|
 | ||||
| A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Meropenem-Vaborbactam in Children With Complicated Urinary Tract Infection, Including Acute Pyelonephritis | Rempex (a wholly owned subsidiary of Melinta Therapeutics, LLC) | NA |
ACTIVE NOT RECRUITING
(Sep 1, 2026)
| PHASE2 |
| Dose-finding, Pharmacokinetics, and Safety of VABOMERE in Pediatric Subjects With Bacterial Infections | Rempex (a wholly owned subsidiary of Melinta Therapeutics, LLC) | NA |
COMPLETED
(Aug 1, 2026)
| PHASE1 |
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List